These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 28596381)

  • 21. Beneficial effects of bile acid receptor agonists in pulmonary disease models.
    Comeglio P; Morelli A; Adorini L; Maggi M; Vignozzi L
    Expert Opin Investig Drugs; 2017 Nov; 26(11):1215-1228. PubMed ID: 28949776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bile acid receptors in non-alcoholic fatty liver disease.
    Li Y; Jadhav K; Zhang Y
    Biochem Pharmacol; 2013 Dec; 86(11):1517-24. PubMed ID: 23988487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery, optimization, and evaluation of non-bile acid FXR/TGR5 dual agonists.
    Miyata S; Kawashima Y; Sakai M; Matsubayashi M; Motoki K; Miyajima Y; Watanabe Y; Chikamatsu N; Taniguchi T; Tokuyama R
    Sci Rep; 2021 Apr; 11(1):9196. PubMed ID: 33911126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bile acid signaling in renal water regulation.
    Li S; Li C; Wang W
    Am J Physiol Renal Physiol; 2019 Jul; 317(1):F73-F76. PubMed ID: 31091123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term Administration of Nuclear Bile Acid Receptor FXR Agonist Prevents Spontaneous Hepatocarcinogenesis in Abcb4
    Cariello M; Peres C; Zerlotin R; Porru E; Sabbà C; Roda A; Moschetta A
    Sci Rep; 2017 Sep; 7(1):11203. PubMed ID: 28894223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SAR studies on FXR modulators led to the discovery of the first combined FXR antagonistic/TGR5 agonistic compound.
    Lamers C; Merk D; Gabler M; Flesch D; Kaiser A; Schubert-Zsilavecz M
    Future Med Chem; 2016; 8(2):133-48. PubMed ID: 26824277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic Bile Acid Reuptake in the Rat Depends on Bile Acid Conjugation but Not on Agonistic Properties towards FXR and TGR5.
    Trammell SAJ; Svenningsen JS; Holst JJ; Gillum MP; Kuhre RE
    Molecules; 2020 May; 25(10):. PubMed ID: 32443832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation.
    Chiang JY; Pathak P; Liu H; Donepudi A; Ferrell J; Boehme S
    Dig Dis; 2017; 35(3):241-245. PubMed ID: 28249273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice.
    Donepudi AC; Boehme S; Li F; Chiang JY
    Hepatology; 2017 Mar; 65(3):813-827. PubMed ID: 27351453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A naturally occurring FXR agonist, alisol B 23-acetate, protects against renal ischemia-reperfusion injury.
    Luan ZL; Ming WH; Sun XW; Zhang C; Zhou Y; Zheng F; Yang YL; Guan YF; Zhang XY
    Am J Physiol Renal Physiol; 2021 Nov; 321(5):F617-F628. PubMed ID: 34569253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice.
    Gai Z; Gui T; Hiller C; Kullak-Ublick GA
    J Biol Chem; 2016 Jan; 291(5):2397-411. PubMed ID: 26655953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intolerance.
    Yan X; Li P; Tang Z; Feng B
    BMC Endocr Disord; 2017 Sep; 17(1):60. PubMed ID: 28946907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model of nonalcoholic steatohepatitis.
    Hu YB; Liu XY; Zhan W
    Drug Des Devel Ther; 2018; 12():2213-2221. PubMed ID: 30038487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma membrane-bound G protein-coupled bile acid receptor attenuates liver ischemia/reperfusion injury via the inhibition of toll-like receptor 4 signaling in mice.
    Yang H; Zhou H; Zhuang L; Auwerx J; Schoonjans K; Wang X; Feng C; Lu L
    Liver Transpl; 2017 Jan; 23(1):63-74. PubMed ID: 27597295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria.
    Wang XX; Jiang T; Shen Y; Adorini L; Pruzanski M; Gonzalez FJ; Scherzer P; Lewis L; Miyazaki-Anzai S; Levi M
    Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1587-96. PubMed ID: 19776172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the bile acid receptors TGR5 and FXR in the spinal dorsal horn alleviates neuropathic pain.
    Wu Y; Qiu Y; Su M; Wang L; Gong Q; Wei X
    CNS Neurosci Ther; 2023 Jul; 29(7):1981-1998. PubMed ID: 36880297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Semisynthetic bile acid FXR and TGR5 agonists: physicochemical properties, pharmacokinetics, and metabolism in the rat.
    Roda A; Pellicciari R; Gioiello A; Neri F; Camborata C; Passeri D; De Franco F; Spinozzi S; Colliva C; Adorini L; Montagnani M; Aldini R
    J Pharmacol Exp Ther; 2014 Jul; 350(1):56-68. PubMed ID: 24784847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders.
    Fiorucci S; Mencarelli A; Palladino G; Cipriani S
    Trends Pharmacol Sci; 2009 Nov; 30(11):570-80. PubMed ID: 19758712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbially conjugated bile salts found in human bile activate the bile salt receptors TGR5 and FXR.
    Ay Ü; Leníček M; Haider RS; Classen A; van Eijk H; Koelfat KVK; van der Kroft G; Neumann UP; Hoffmann C; Bolm C; Olde Damink SWM; Schaap FG
    Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38517202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.